相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical characterization of primary hyperoxaluria type 3 in comparison with types 1 and 2
Prince Singh et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)
Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria
Gema Ariceta et al.
KIDNEY INTERNATIONAL REPORTS (2021)
A report from the European Hyperoxaluria Consortium (OxalEurope) Registry on a large cohort of patients with primary hyperoxaluria type 3
Cristina Martin-Higueras et al.
KIDNEY INTERNATIONAL (2021)
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
Sander F. Garrelfs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
End Points for Clinical Trials in Primary Hyperoxaluria
Dawn S. Milliner et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Reduction in urinary oxalate excretion in mouse models of Primary Hyperoxaluria by RNA interference inhibition of liver lactate dehydrogenase activity
Kyle D. Wood et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up
Sander F. Garrelfs et al.
KIDNEY INTERNATIONAL (2019)
Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria
Chengjung Lai et al.
MOLECULAR THERAPY (2018)
Predictors of Incident ESRD among Patients with Primary Hyperoxaluria Presenting Prior to Kidney Failure
Fang Zhao et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria
Katharina Hopp et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Renal function can be impaired in children with primary hyperoxaluria type 3
Lise Allard et al.
PEDIATRIC NEPHROLOGY (2015)
Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type
Giorgia Mandrile et al.
KIDNEY INTERNATIONAL (2014)
NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy
Felix Knauf et al.
KIDNEY INTERNATIONAL (2013)
Primary Hyperoxaluria
Pierre Cochat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Hereditary causes of kidney stones and chronic kidney disease
Vidar O. Edvardsson et al.
PEDIATRIC NEPHROLOGY (2013)
An update on primary hyperoxaluria
Bernd Hoppe
NATURE REVIEWS NEPHROLOGY (2012)
Primary Hyperoxaluria Type III Gene HOGA1 (Formerly DHDPSL) as a Possible Risk Factor for Idiopathic Calcium Oxalate Urolithiasis
Carla G. Monico et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Primary Hyperoxaluria
Jerome Harambat et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY (2011)
Mutations in DHDPSL Are Responsible For Primary Hyperoxaluria Type III
Ruth Belostotsky et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome
Jerome Harambat et al.
KIDNEY INTERNATIONAL (2010)
New Equations to Estimate GFR in Children with CKD
George J. Schwartz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Hydroxyproline ingestion and urinary oxalate and glycolate excretion
J. Knight et al.
KIDNEY INTERNATIONAL (2006)
A preliminary account of the properties of recombinant human glyoxylate reductase (GRHPR), LDHA and LDHB with glyoxylate, and their potential roles in its metabolism
K Mdluli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
International registry for primary Hyperoxaluria
JC Lieske et al.
AMERICAN JOURNAL OF NEPHROLOGY (2005)
分享论文
